MMSI
Merit Medical Systems, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+31/100
Last price
84.96
▼ 2.18 (2.50%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
87.00
Prev close
87.14
Day high
88.90
Day low
84.22
Volume
587.66K
Market cap
$5.07B
P/E (TTM)
35.85
52W range
59.74 – 94.75
Day trading desk
Gap from prior close
-0.16%
Prior close 87.14
VWAP
85.00
-0.05% from price
Relative volume
1.20×
Normal
Session range
10.31%
84.22 – 92.90
Position in range
9%
Near session low
ATR (14D)
1.96
2.31% of price
Prior day high
87.57
PDH
Prior day low
84.74
PDL
Bid / ask spread
—
Quote not published
Session volume
955.52K
Avg 798.36K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.31%
-5.3%
1M
-5.18%
-6.3%
3M
+19.56%
+15.0%
6M
+26.05%
+7.9%
YTD
-3.61%
-17.9%
1Y
+0.89%
-15.5%
3Y
+23.09%
-59.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MMSI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+38.88K
Net buying
Buy transactions
19
72.83K shares
Sell transactions
3
33.95K shares
Net transactions
+22
Buys less sells
Sell : buy shares
0.5 : 1
Mixed
Insider-held shares
1.46M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 4, 26 | LEWIS SHERI Officer |
STOCK | 8.37K | $0 | Direct |
| Aug 24, 26 | VOIGT MICHEL JAMES Officer |
STOCK | 650 | $0 | Direct |
| Aug 24, 26 | PETERSON NEIL W Chief Operating Officer |
SELL | 7.50K | $678.36K | Direct |
| Aug 4, 26 | PETERSON NEIL W Chief Operating Officer |
SELL | 21.45K | $1.82M | Direct |
| Jun 15, 26 | VOIGT MICHEL JAMES Officer |
STOCK | 65 | $0 | Direct |
| Jun 5, 26 | LLOYD BRIAN G Officer |
STOCK | 2.00K | $0 | Direct |
| May 20, 26 | GUNDERSON THOMAS JAMES Director |
CONVERSION | 21.25K | $1.11M | Direct |
| May 18, 26 | WARD SCOTT RAYMOND Director |
STOCK | 3.46K | $0 | Direct |
| May 18, 26 | CARPENTER LONNY J Director |
STOCK | 3.46K | $0 | Direct |
| May 18, 26 | MILLNER F ANN Director |
STOCK | 3.46K | $0 | Direct |
| May 18, 26 | GUNDERSON THOMAS JAMES Director |
STOCK | 3.46K | $0 | Direct |
| May 18, 26 | KAISER LAURA S. Director |
STOCK | 3.46K | $0 | Direct |
| May 18, 26 | WARD LYNNE N. Director |
STOCK | 3.46K | $0 | Direct |
| May 18, 26 | MCDONNELL MICHAEL R Director |
STOCK | 3.46K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARONSON MARTHA GOLDBERG |
Chief Executive Officer | 49.79K | Purchase |
CARPENTER LONNY J |
Director | 20.82K | Stock Award(Grant) |
GUNDERSON THOMAS JAMES |
Director | 60.74K | Conversion of Exercise of derivative security |
LAMPROPOULOS FRED P |
Officer and Director | 1.13M | Sale |
LLOYD BRIAN G |
Officer | 62.13K | Stock Gift |
MILLNER F ANN |
Director | 38.00K | Stock Award(Grant) |
PARRA RAUL JR. |
Chief Financial Officer | 61.54K | Purchase |
PETERSON NEIL W |
Chief Operating Officer | 18.05K | Sale |
SMITH CHRISTIAN ADAM |
Officer | — | Purchase |
VOIGT MICHEL JAMES |
Officer | 47.68K | Stock Gift |
Fundamentals
Market cap$5.07B
Enterprise value$5.44B
Revenue (TTM)$1.58B
Gross profit$781.73M
EBITDA$338.94M
Net income$145.56M
EPS (TTM)$2.37
Free cash flow$173.90M
Total cash$448.70M
Total debt$820.12M
Book value / share$28.13
Shares outstanding59.71M
Float58.30M
Short % of float8.91%
Dividend yield0.00%
Beta (5Y)0.51
Valuation & profitability ratios
Trailing P/E35.85
Forward P/E18.42
PEG ratio1.58
Price / sales—
Price / book3.02
EV / revenue3.45
EV / EBITDA16.06
Gross margin49.51%
Operating margin14.46%
Profit margin9.22%
Return on equity9.19%
Return on assets4.92%
Debt / equity48.82
Current ratio4.20
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.52B | $1.36B | $1.26B | $1.15B | +11.8% |
| Operating revenue | $1.52B | $1.36B | $1.26B | $1.15B | +11.8% |
| Cost of revenue | $777.64M | $713.18M | $673.49M | $631.88M | +9.0% |
| Gross profit | $738.27M | $643.33M | $583.87M | $519.10M | +14.8% |
| Research & development | $97.35M | $87.47M | $82.73M | $75.51M | +11.3% |
| Selling, general & admin | $455.21M | $399.73M | $373.68M | $342.52M | +13.9% |
| Total operating expense | $552.57M | $487.20M | $456.40M | $418.04M | +13.4% |
| Operating income | $185.70M | $156.14M | $127.47M | $101.06M | +18.9% |
| Net interest income | -$11.39M | -$4.99M | -$13.05M | -$5.90M | -128.3% |
| Pre-tax income | $170.94M | $149.99M | $112.09M | $82.63M | +14.0% |
| Tax provision | $42.45M | $29.64M | $17.68M | $8.11M | +43.2% |
| Net income | $128.49M | $120.36M | $94.41M | $74.52M | +6.8% |
| Net income to common | $128.49M | $120.36M | $94.41M | $74.52M | +6.8% |
| Basic EPS | 2.17 | 2.07 | 1.64 | 1.31 | +4.8% |
| Diluted EPS | 2.13 | 2.03 | 1.62 | 1.29 | +4.9% |
| EBIT | $197.40M | $181.21M | $127.60M | $88.97M | +8.9% |
| EBITDA | $332.05M | $295.94M | $228.89M | $181.17M | +12.2% |
| Basic shares | 59.16M | 58.22M | 57.59M | 56.81M | +1.6% |
| Diluted shares | 60.46M | 59.37M | 58.36M | 57.67M | +1.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $446.40M | $376.71M | $587.04M | $58.41M | — | +18.5% |
| Cash & short-term investments | $446.40M | $376.71M | $587.04M | $58.41M | — | +18.5% |
| Accounts receivable | $203.71M | $190.24M | $177.88M | $164.68M | — | +7.1% |
| Inventory | $333.70M | $306.06M | $303.87M | $265.99M | — | +9.0% |
| Total current assets | $1.04B | $923.77M | $1.11B | $529.08M | — | +12.6% |
| Property, plant & equipment | $516.00M | $451.67M | $446.57M | $448.24M | — | +14.2% |
| Goodwill & intangibles | $1.04B | $961.78M | $708.12M | $635.69M | — | +8.6% |
| Total assets | $2.69B | $2.42B | $2.33B | $1.66B | — | +11.1% |
| Total current liabilities | $239.76M | $216.40M | $203.56M | $220.65M | — | +10.8% |
| Current debt | — | — | — | $11.25M | $8.44M | — |
| Long-term debt | $734.04M | $729.55M | $823.01M | $186.76M | — | +0.6% |
| Total debt | $821.57M | $794.66M | $891.36M | $268.75M | — | +3.4% |
| Total liabilities | $1.10B | $1.04B | $1.12B | $519.57M | — | +6.0% |
| Retained earnings | $824.03M | $695.54M | $575.18M | $480.77M | — | +18.5% |
| Shareholder equity | $1.58B | $1.38B | $1.20B | $1.14B | — | +14.9% |
| Working capital | $800.39M | $707.37M | $904.91M | $308.44M | — | +13.1% |
| Net tangible assets | $539.81M | $417.58M | $493.88M | $508.70M | — | +29.3% |
| Shares issued | 59.42M | 58.74M | 57.86M | 57.31M | — | +1.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $128.49M | $120.36M | $94.41M | $74.52M | +6.8% |
| Depreciation & amortisation | $134.65M | $114.73M | $101.29M | $92.20M | +17.4% |
| Stock-based compensation | $43.46M | $28.47M | $21.33M | $18.04M | +52.6% |
| Change in working capital | -$23.34M | -$36.95M | -$70.02M | -$71.40M | +36.8% |
| Operating cash flow | $297.37M | $220.80M | $145.15M | $114.29M | +34.7% |
| Capital expenditure | -$84.84M | -$38.04M | -$36.70M | -$48.20M | -123.0% |
| Investing cash flow | -$247.39M | -$368.65M | -$175.35M | -$57.40M | +32.9% |
| Financing cash flow | $16.00M | -$60.01M | $559.27M | -$60.26M | +126.7% |
| Free cash flow | $212.53M | $182.76M | $108.45M | $66.09M | +16.3% |
| End cash position | $448.55M | $378.77M | $589.14M | $60.56M | +18.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $418.84M | $381.88M | $393.94M | $384.16M | $382.46M | +9.7% |
| Operating revenue | $418.84M | $381.88M | $393.94M | $384.16M | $382.46M | +9.7% |
| Cost of revenue | $203.68M | $197.08M | $198.58M | $197.75M | $197.97M | +3.3% |
| Gross profit | $215.17M | $184.80M | $195.35M | $186.41M | $184.49M | +16.4% |
| Research & development | $25.39M | $22.61M | $26.54M | $23.97M | $24.37M | +12.3% |
| Selling, general & admin | $129.23M | $118.21M | $114.83M | $119.80M | $113.10M | +9.3% |
| Total operating expense | $154.62M | $140.82M | $141.37M | $143.77M | $137.46M | +9.8% |
| Operating income | $60.55M | $43.98M | $53.98M | $42.64M | $47.02M | +37.7% |
| Net interest income | -$8.37M | -$2.63M | -$2.46M | -$3.14M | -$3.01M | -218.6% |
| Pre-tax income | $51.31M | $53.55M | $51.06M | $38.54M | $43.38M | -4.2% |
| Tax provision | $12.51M | $12.55M | $13.05M | $10.79M | $10.80M | -0.3% |
| Net income | $38.80M | $40.99M | $38.01M | $27.75M | $32.58M | -5.3% |
| Net income to common | $38.80M | $40.99M | $38.01M | $27.75M | $32.58M | -5.3% |
| Basic EPS | 0.65 | 0.69 | 0.64 | 0.47 | 0.55 | -5.8% |
| Diluted EPS | 0.65 | 0.68 | 0.63 | 0.46 | 0.54 | -4.4% |
| EBIT | $63.43M | $60.07M | $57.42M | $45.29M | $50.15M | +5.6% |
| EBITDA | $97.40M | $93.42M | $91.75M | $79.54M | $83.96M | +4.3% |
| Basic shares | 59.68M | 59.51M | 59.34M | 59.24M | 59.14M | +0.3% |
| Diluted shares | 60.01M | 60.01M | 60.03M | 59.92M | 60.61M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $448.70M | $488.08M | $446.40M | $392.46M | $341.82M | -8.1% |
| Cash & short-term investments | $448.70M | $488.08M | $446.40M | $392.46M | $341.82M | -8.1% |
| Accounts receivable | $224.24M | $206.45M | $203.71M | $210.29M | $204.16M | +8.6% |
| Inventory | $374.11M | $352.39M | $333.70M | $326.55M | $323.31M | +6.2% |
| Total current assets | $1.11B | $1.10B | $1.04B | $985.53M | $923.07M | +0.9% |
| Property, plant & equipment | $520.52M | $520.33M | $516.00M | $506.50M | $499.26M | +0.0% |
| Goodwill & intangibles | $1.15B | $1.02B | $1.04B | $1.05B | $1.07B | +13.4% |
| Total assets | $2.86B | $2.72B | $2.69B | $2.63B | $2.59B | +5.3% |
| Total current liabilities | $264.93M | $216.87M | $239.76M | $230.47M | $225.57M | +22.2% |
| Long-term debt | $736.26M | $735.16M | $734.04M | $732.92M | $731.79M | +0.1% |
| Total debt | $820.12M | $821.56M | $821.57M | $821.15M | $820.55M | -0.2% |
| Total liabilities | $1.18B | $1.09B | $1.10B | $1.10B | $1.10B | +8.4% |
| Retained earnings | $903.83M | $865.02M | $824.03M | $786.02M | $758.27M | +4.5% |
| Shareholder equity | $1.68B | $1.63B | $1.58B | $1.53B | $1.49B | +3.3% |
| Working capital | $847.30M | $884.90M | $800.39M | $755.06M | $697.50M | -4.2% |
| Net tangible assets | $528.01M | $611.30M | $539.81M | $483.58M | $421.33M | -13.6% |
| Shares issued | 59.71M | 59.66M | 59.42M | 59.29M | 59.22M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $38.80M | $40.99M | $38.01M | $27.75M | $32.58M | -5.3% |
| Depreciation & amortisation | $33.97M | $33.35M | $34.33M | $34.24M | $33.80M | +1.9% |
| Stock-based compensation | $12.91M | $8.96M | $9.90M | $13.61M | $10.87M | +44.1% |
| Change in working capital | -$18.76M | -$32.07M | $7.97M | -$2.35M | $4.49M | +41.5% |
| Operating cash flow | $69.28M | $40.68M | $98.51M | $74.98M | $83.31M | +70.3% |
| Capital expenditure | -$18.19M | -$16.77M | -$25.26M | -$23.47M | -$14.59M | -8.5% |
| Investing cash flow | -$110.13M | $7.73M | -$50.34M | -$24.07M | -$143.35M | -1,524.0% |
| Financing cash flow | $948.00K | -$6.29M | $5.06M | -$365.00K | $4.35M | +115.1% |
| Free cash flow | $51.09M | $23.91M | $73.25M | $51.51M | $68.72M | +113.6% |
| End cash position | $450.91M | $490.25M | $448.55M | $394.56M | $343.92M | -8.0% |
Options analytics
Put / call volume
0.06
Call-heavy session
Put / call open interest
0.14
Positioning, not flow
Max pain
75.00
-11.7% from spot
ATM implied vol
78.5%
Nearest strike to spot
Skew (10% OTM)
+24.8%
Puts bid over calls
Call volume
288
Contracts, this expiry
Put volume
17
Contracts, this expiry
Heaviest call OI
90.00
246 contracts
Heaviest put OI
60.00
20 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.96 | 1.19 | +24.0% |
| Mar 2026 | 0.83 | 0.94 | +12.8% |
| Dec 2025 | 0.95 | 1.04 | +9.0% |
| Sep 2025 | 0.83 | 0.92 | +11.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.03 | 10 | $410.38M | +6.8% |
| Next quarter | 1.14 | 10 | $425.02M | +7.9% |
| Current year | 4.30 | 10 | $1.64B | +8.0% |
| Next year | 4.61 | 10 | $1.74B | +6.1% |
Analyst targets & ownership
Mean target$101.45
High target$123.00
Low target$83.00
Implied upside19.41%
Analyst count11
ConsensusBUY
Strong buy / Buy5 / 4
Hold2
Sell / Strong sell0 / 0
Held by insiders2.45%
Held by institutions107.56%
Institutions holding547
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
86.66
-1.96% from price
SMA 20
86.48
-1.76% from price
SMA 50
87.73
-3.16% from price
SMA 100
77.93
+9.01% from price
SMA 200
76.72
+10.74% from price
EMA 12
86.45
-1.72% from price
EMA 26
86.71
-2.01% from price
EMA 50
85.10
-0.16% from price
RSI (14)
42.4
Neutral
MACD (12,26,9)
-0.26
Hist -0.21
ATR (14)
1.96
2.31% of price
Realised vol 30D
17.6%
Annualised
Bollinger upper
88.10
20, 2σ
Bollinger lower
84.86
20, 2σ
50 / 200 cross
Golden
87.73 vs 76.72
Trend bias
Above 200
+10.74%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.43
Less volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
17.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-35.3%
Peak to trough
Max drawdown 5Y
-45.3%
Peak to trough
ATR 14
1.96
2.31% of price
Beta (reported)
0.51
5Y monthly, from filing
Short interest
Shares short
3.93M
Prior 3.45M
Change vs prior
+13.9%
Shorts adding
% of float
8.91%
Normal
% of shares out
6.59%
Against total outstanding
Days to cover
6.2
Crowded exit
Float
58.30M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 29, 26 | Needham | MAINTAINED | Buy | Buy |
| Aug 13, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Aug 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 31, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 31, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 31, 26 | BTIG | MAINTAINED | Buy | Buy |
| May 1, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| May 1, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 1, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split5:4
Split dateMay 6, 2011
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-20
Corporate Changes & Voting Matters
8-K · 2026-07-30
Offering Registrations
S-8 · 2026-06-29
Annual report of employee stock purchase
11-K · 2026-06-26
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-19
Offering Registrations
S-8 · 2026-05-15
Periodic Financial Reports
10-Q · 2026-04-30
Headlines
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
GlobeNewswire · 6h ago
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Zacks · 12h ago
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Zacks · 13h ago
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
Zacks · 13h ago
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
Zacks · 5d ago
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Zacks · 6d ago
1 Profitable Stock to Own for Decades and 2 We Brush Off
StockStory · 9d ago
2 Reasons to Sell MMSI and 1 Stock to Buy Instead
StockStory · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.